 | Articles: Drug/Product Approvals |

U.S. District Court Upholds DURAGESIC® Patent
Janssen Pharmaceutica, 03/30/04
Statement on Generic Oxycodone Hydrochloride Extended Release Tablets
Center for Drug Evaluation and Research, 03/29/04
SCULPTRA¿ From Dermik Laboratories Receives Recommendation For Approval With Conditions From FDA Advisory Panel
Aventis, 03/29/04
Long-term treatment with Avodart® reduces the risk of BPH progression: The patients preferred outcome
GlaxoSmithKline, 03/26/04
FOSAMAX® Continues to Help Build Bone Through 10 Years of Treatment, Study in New England Journal of Medicine Finds
Merck & Co., 03/19/04
FDA Approves New Chewable Formulation Of Zyrtec®
Pfizer, 03/19/04
New Relief for Your Aching Head
Ivanhoe, 03/12/04
FDA Approves New Kidney Disease Drug
Corporate News Releases, 03/09/04
Cell Therapeutics, Inc. to Initiate Pivotal Trial for Pixantrone in Relapsed Aggressive Non-Hodgkins Lymphoma
CTI, 03/04/04
Nabi Biopharmaceuticals Altastaph¿ Receives FDA Fast Track Designation
Nabi Biopharmaceuticals, 03/04/04
|
Receive daily email updates on Drug/Product Approvals
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
193 Available Pages
 |
 |
| Read a Different Specialty |
 |
|
|
|
 |
| Profession Index |
 |
|
|
|
 |
|
|
|
| Sponsor |
|